Medicare CED Could Enhance Efficiency Of FDA Post-Approval Studies – CMS Draft Guidance

Medicare’s coverage with evidence development policy could help enhance the efficiency of research conducted under FDA post-approval requirements, CMS says in a draft guidance on CED released Nov. 29.